Page 19 - X. Stem cell biology
P. 19

Oct-4, Sox2, Klf-4, and c-Myc Reprogramming Factors Delay
       Premature Senescence through the Activation of Cyclin D1

                                  Junghoon Kim, and Jungho Kim


        ABSTRACT

   Although pluripotent stem cells hold great promise in the fields of human disease modeling and regenerative medicine, the molecular basis of Oct-4, Sox2, Klf4, and c-Myc (OSKM)-induced
   cellular reprogramming remains unclear. To investigate the molecular mechanisms involved in cellular reprogramming, we studied the immediate effects of expression of the OSKM
   reprogramming factors on mouse embryonic fibroblasts (MEFs) in this study. Induction of the OSKM reprogramming factors significantly altered primary MEF growth properties. Although MEFs
   not expressing the reprogramming factors underwent replicative senescence within 9–12 days in culture, MEFs expressing the four reprogramming factors proliferated continuously throughout the
   duration of the experiment, suggesting that expression of the OSKM reprogramming factors inhibits or delays replicative senescence. Cell cycle progression by the reprogramming factors was
   accompanied by accumulation of Cyclin D1 through the early stages of reprogramming in MEFs, leading us to hypothesize that it might play a positive role in cellular reprogramming. Consistent
   with this hypothesis, forced Cyclin D1 expression enhanced reprogramming if administered concomitant with expression of the OSKM reprogramming factors. Most importantly, unlike wild-type
   MEFs expressing reprogramming factors, the number of emerging alkaline phosphatase-positive cyclin D1-null colonies was significantly reduced and cyclin D1-null MEFs were unable to initiate
   mesenchymal-to-epithelial transition. Our studies demonstrate that cyclin D1 is an essential gene in the reprogramming process and that activation of cyclin D1 by reprogramming factors is an
   important process for somatic cell reprogramming
                                                          The G1 cyclin/CDK and CDK inhibitor (CDKI) pathways are
                                                          both activated during the early stage of reprogramming
         RESULTS
    Expression of the OSKM reprogramming factors enhances MEF proliferation during the
    early stage of reprogramming


                                                           Figure 4. Effect of expression of the OSKM reprogramming factors
                                                            on cell cycle regulatory proteins
                                                           Overexpression of Cyclin D1 improves
                                                           the reprogramming efficiency of 4F2A MEFs

    Figure 1. Stimulation of 4F2A MEF growth upon induction of the OSKM reprogramming factors. (A) Schematic
    representation of the tetracycline-inducible 4F2A system in 4F2A MEFs generated from transgenic homozygous
    double mutant R26 rtTA-M2;Col1a1 4F2A mice
    Expression of the OSKM reprogramming factors increases the incorporation of
    BrdU and compromises replicative senescence ex vivo

                                                            Figure 5. Forced Cyclin D1 expression enhances reprogramming
                                                           Cyclin D1 is an essential gene in the reprogramming process








    Figure 2. Quantification of differences in proliferation based on BrdU, Ki-67, and SA- -Gal staining after
    induction of the OSKM reprogramming factors. (A and B) DNA synthesis induced by OSKM expression in 4F2A
    MEFs.
    .
    Expression of the OSKM reprogramming factors induces Cyclin D1
                                                          Figure 6. Growth characteristics of Tet(2);4F2A(2);Cyclin D1+/+ (Cyclin D1+/+) and Tet(2);4F2A(2);Cyclin
                                                          D1-/- (Cyclin D1-/-) MEFs treated with doxycycline. (A) Experimental scheme used to generate
                                                          heterozygous mutant Cyclin D1;4F2A mice [Tet(2);4F2A(2);Cyclin D1+/-].




                                                          Figure 7. Cyclin D1 is required for OSKM-mediated cellular reprogramming of MEFs.


    Figure 3. Up-regulation of cyclin D1 gene expression in 4F2A MEFs expressing the OSKM reprogramming
    factors during the early stage of reprogramming
       CONCLUSION
                                                          Figure 8. Cyclin D2 or Cyclin D3 can replace Cyclin D1 function.
   This study identified cyclin D1 as an essential gene in the reprogramming process and  Figure 9. Expression of Cyclin D1 in MEFs expressing Oct-4, Sox2, and Klf4 reprogramming factors in the
                                                          absence of c-Myc during the early stage of reprogramming.
   demonstrated that cyclin D1-null MEFs fail to initiate MET. Although this finding suggests that  .
   induction of Cyclin D1 by the OSKM reprogramming factors is essential for inactivation of the  Cyclin D1-null MEFs cannot initiate MET
   Rb tumor suppressor protein and MET during the initial stage of cellular reprogramming, the
   functional contribution of this protein to the conversion of somatic cells into iPSCs remains
   unknown. Future studies on the detailed mechanisms explaining how Cyclin D1 contributes to
   reprogramming will provide insights into the mechanisms of induced pluripotency. Therefore,
   the close interactions between Cyclin D1 and reprogramming barriers probably underlie the
   essential functions of Cyclin D1 in regulating cellular reprogramming and their regulatory
   circuitry.
       REFERENCES                                         Figure 10. Cyclin D1 is required for MET during the cellular reprogramming of MEFs.
                                                          .
   .Yamanaka, S. (2012) Induced pluripotent stem cells: past, present, and future, Cell Stem Cell. 10, 678-84.
    Contact information
   Laboratory of Molecular and Cellular Biology, Department of Life Science, Sogang University, Seoul 40107, Korea
   E-mail : jkim@sogang.ac.kr, Phone: 82-2-715-8461
   14   15   16   17   18   19   20